Total Payments
$85,649
2024 Payments
$184.94
Companies
9
Transactions
120
Payment Breakdown by Category
Other$71,816 (83.8%)
Travel$11,954 (14.0%)
Food & Beverage$1,879 (2.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $71,816 | 33 | 83.8% |
| Travel and Lodging | $11,954 | 60 | 14.0% |
| Food and Beverage | $1,879 | 27 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $84,791 | 108 | $0 (2020) |
| Valeritas, Inc. | $242.85 | 2 | $0 (2019) |
| Lilly USA, LLC | $163.06 | 3 | $0 (2024) |
| Insulet Corporation | $126.72 | 1 | $0 (2017) |
| Corcept Therapeutics | $124.10 | 1 | $0 (2019) |
| Medtronic MiniMed, Inc. | $121.13 | 2 | $0 (2017) |
| Medtronic, Inc. | $46.21 | 1 | $0 (2022) |
| Tandem Diabetes Care, Inc. | $21.88 | 1 | $0 (2024) |
| AbbVie Inc. | $11.67 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $184.94 | 4 | Lilly USA, LLC ($163.06) |
| 2022 | $46.21 | 1 | Medtronic, Inc. ($46.21) |
| 2021 | $11.67 | 1 | AbbVie Inc. ($11.67) |
| 2020 | $11,079 | 11 | Merck Sharp & Dohme Corporation ($11,079) |
| 2019 | $50,956 | 68 | Merck Sharp & Dohme Corporation ($50,693) |
| 2018 | $23,020 | 31 | Merck Sharp & Dohme Corporation ($23,020) |
| 2017 | $352.01 | 4 | Insulet Corporation ($126.72) |
All Payment Transactions
120 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/16/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: Diabetes | ||||||
| 03/11/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $28.43 | General |
| Category: Diabetes | ||||||
| 02/14/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: Endocrinology | ||||||
| 01/24/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $109.72 | General |
| Category: Diabetes | ||||||
| 05/14/2022 | Medtronic, Inc. | INPEN SMART INSULIN DELIVERY SYSTEM (Device) | Food and Beverage | In-kind items and services | $46.21 | General |
| Category: Continuous Glucose Monitoring | ||||||
| 06/02/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2020 | Merck Sharp & Dohme Corporation | STEGLUJAN (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,815.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/20/2020 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,815.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/20/2020 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,310.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/27/2020 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,310.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/19/2020 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,310.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/10/2020 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Travel and Lodging | Cash or cash equivalent | $25.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/09/2020 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Travel and Lodging | Cash or cash equivalent | $25.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/05/2020 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Food and Beverage | In-kind items and services | $122.73 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/01/2020 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/26/2020 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Food and Beverage | In-kind items and services | $70.97 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/30/2020 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/22/2019 | Merck Sharp & Dohme Corporation | STEGLUJAN (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,815.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/18/2019 | Merck Sharp & Dohme Corporation | STEGLUJAN (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,815.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/01/2019 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,310.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/01/2019 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/31/2019 | Merck Sharp & Dohme Corporation | STEGLUJAN (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,815.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/30/2019 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Travel and Lodging | In-kind items and services | $385.07 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/27/2019 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,310.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/27/2019 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: ENDOCRINOLOGY | ||||||
About Dr. James Clifford, M.D
Dr. James Clifford, M.D is a Internal Medicine healthcare provider based in Imperial Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/03/2007. The National Provider Identifier (NPI) number assigned to this provider is 1619034030.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Clifford, M.D has received a total of $85,649 in payments from pharmaceutical and medical device companies, with $184.94 received in 2024. These payments were reported across 120 transactions from 9 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($71,816).
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine, Internal Medicine
- Location Imperial Beach, CA
- Active Since 01/03/2007
- Last Updated 04/16/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1619034030
Products in Payments
- STEGLATRO (Drug) $68,848
- STEGLUJAN (Drug) $7,260
- JANUVIA (Drug) $5,452
- V-GO (Device) $242.85
- MOUNJARO (Drug) $138.15
- Omnipod (Device) $126.72
- Korlym (Drug) $124.10
- Minimed 670G System (Device) $121.13
- INPEN SMART INSULIN DELIVERY SYSTEM (Device) $46.21
- JARDIANCE (Drug) $24.91
- t:slim X2 Insulin Pump with Control-IQ (Device) $21.88
- UBRELVY (Drug) $11.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.